Friday, August 7, 2015

Nature Biotechnology Contents: Volume 33 pp 781 - 884

If you are unable to see the message below, click here to view.
Nature Biotechnology


Advertisement
Q2 Solutions can enhance your precision medicine efforts 
by providing comprehensive genomic and biomarker discovery and development expertise, scientific acumen, data informatics and clinical trial operational excellence. Let our experience and insights help you avoid obstacles and optimize your path to developing new personalized medicines and companion diagnostics.
TABLE OF CONTENTS

August 2015 Volume 33, Issue 8

Editorial
News
Bioentrepreneur
Opinion and Comment
Features
News and Views
Computational Biology
Research
Careers and Recruitment

Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
Advertisement

BIOPHARMA DEALMAKERS
BIOPHARMA DEALMAKERSCompany Profiles and Partnering Opportunities


 
Advertisement
Noncoding RNAs in Endocrinology 

Noncoding RNAs have important roles in the development and regulation of the endocrine system. This web collection on noncoding RNAs in endocrinology highlights current and future applications of noncoding RNAs as diagnostic and prognostic biomarkers and as therapeutic targets for personalized management of patients with a wide range of endocrine diseases.

Access the collection online.
 
 

Editorial

Top

Old boy biotech   p781
doi:10.1038/nbt.3308
No matter where you look in biopharmaceutical boardrooms, gender bias is evident. Is it so difficult to actually acknowledge this pernicious bias and actively discourage all-male boards?

News

Top

'Financial toxicity' looms as cancer combinations proliferate   pp783 - 784
Chris Morrison
doi:10.1038/nbt0815-783

New class PCSK9 blockers stride into cholesterol market   pp785 - 786
Cormac Sheridan
doi:10.1038/nbt0815-785

Microbial cocktails join fecal transplants in IBD treatment trials   pp787 - 788
Mark Ratner
doi:10.1038/nbt0815-787

Blockbuster expectations for hepatitis B therapeutic vaccine   p789
Suzanne Elvidge
doi:10.1038/nbt0815-789

NCI-MATCH pairs tumor mutations with matching drugs   pp790 - 791
Vicki Brower
doi:10.1038/nbt0815-790

Alnylam, Dicerna tussle over RNAi tech   p791
doi:10.1038/nbt0815-791a

Court invalidates Sequenom's prenatal test patent   p791
doi:10.1038/nbt0815-791b

PureTech floats away   p792
doi:10.1038/nbt0815-792a

BGI goes head-to-head with Illumina   p792
doi:10.1038/nbt0815-792b

Oxitec trials GM sterile moth to combat agricultural infestations   pp792 - 793
Emily Waltz
doi:10.1038/nbt0815-792c

Around the world in a month   p793
doi:10.1038/nbt0815-793

Data Page

2Q15—Running of the biotech bulls   p794
Walter Yang
doi:10.1038/nbt.3311

Drug pipeline: 2Q15   p795
Laura DeFrancesco
doi:10.1038/nbt.3312

News Feature

To share is human   pp796 - 800
doi:10.1038/nbt.3309
Personal health data are beginning to be shared in the digital world—on mobile devices and the internet. Is the loss of privacy a price worth paying for the presumed benefits? Laura DeFrancesco investigates.

Advertisement
Simple, Rapid, Reproducible Collection of Plasma 
Offering significant advantages for use with LC-MS/MS instruments, Shimadzu's Noviplex Cards allow for rapid collection of a volumetric sample of plasma (2.5 µL) from an unmeasured amount of whole blood (20 to 75 µL) within minutes. They can be used as a single step, solid-phase method for sample preparation and analyte extraction.
Learn more
.

Bioentrepreneur

Top
Building a business

In house expertise   pp801 - 804
Orin Herskowitz
doi:10.1038/nbt.3302

First Rounders Podcast   p804
Rachel King
doi:10.1038/nbt0815-804

Opinion and Comment

Top
Correspondence

Flexible guide-RNA design for CRISPR applications using Protospacer Workbench   pp805 - 806
Cameron Ross MacPherson and Artur Scherf
doi:10.1038/nbt.3291

Health ROI as a measure of misalignment of biomedical needs and resources   pp807 - 811
Lixia Yao, Ying Li, Soumitra Ghosh, James A Evans and Andrey Rzhetsky
doi:10.1038/nbt.3276

Benchmarking the scientific output of the Innovative Medicines Initiative   pp811 - 812
Magda Gunn, Mark Lim, Didi Cross and Michel Goldman
doi:10.1038/nbt.3305

What does the current biotech stock market value?   pp813 - 814
Laura McNamee and Fred Ledley
doi:10.1038/nbt.3303

Commentary

The smart and gentle microscope   pp815 - 818
Nico Scherf and Jan Huisken
doi:10.1038/nbt.3310
New instruments are needed to realize the potential of quantitative and systematic imaging of living samples. But what would such a microscope look like?

Features

Top
Patents

The emergence of agbiogenerics   pp819 - 823
David J Jefferson, Gregory D Graff, Cecilia L Chi-Ham and Alan B Bennett
doi:10.1038/nbt.3306
Although the first major agbiotech product patent has expired, regulatory requirements could continue to allot a significant degree of control to the original right holder.

Recent patents and applications in optogenetics   p824
doi:10.1038/nbt.3324

News and Views

Top

Deep learning for regulatory genomics   pp825 - 826
Yongjin Park and Manolis Kellis
doi:10.1038/nbt.3313
Computational modeling of DNA and RNA targets of regulatory proteins is improved by a deep-learning approach.

See also: Computational Biology by Alipanahi et al.

A time and a place for sugar in your ears   pp827 - 828
Jiahn-Chou Guan and Karen E Koch
doi:10.1038/nbt.3315
Targeting trehalose metabolism improves maize yield under a range of water-deficit conditions.

See also: Research by Nuccio et al.

Research Highlights   p828
doi:10.1038/nbt.3307

New PAMs for Cas   p829
Markus Elsner
doi:10.1038/nbt.3317

A flexible mesh to record the brain   p830
Irene Jarchum
doi:10.1038/nbt.3316

Computational Biology

Top
Analysis

Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning   pp831 - 838
Babak Alipanahi, Andrew Delong, Matthew T Weirauch and Brendan J Frey
doi:10.1038/nbt.3300
The binding specificities of RNA- and DNA-binding proteins are determined from experimental data using a /`deep learning/' approach.

See also: News and Views by Park & Kellis

Research

Top
Brief Communications

Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery   pp839 - 841
Liliana Wroblewska, Tasuku Kitada, Kei Endo, Velia Siciliano, Breanna Stillo et al.
doi:10.1038/nbt.3301
Using RNA-binding proteins to build genetic circuits enables RNA-only synthetic biology.

Engineered CHO cells for production of diverse, homogeneous glycoproteins   pp842 - 844
Zhang Yang, Shengjun Wang, Adnan Halim, Morten Alder Schulz, Morten Frodin et al.
doi:10.1038/nbt.3280
A knockout study of all human glycosyltransferases encoded in CHO cells provides a guide to producing proteins with desired glycosylation patterns.

Articles

Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation   pp845 - 852
Fotios Sampaziotis, Miguel Cardoso de Brito, Pedro Madrigal, Alessandro Bertero, Kourosh Saeb-Parsy et al.
doi:10.1038/nbt.3275
A protocol for generating biliary epithelial cells from human pluripotent stem cells facilitates disease modeling and drug screening.

Directed differentiation of cholangiocytes from human pluripotent stem cells   pp853 - 861
Mina Ogawa, Shinichiro Ogawa, Christine E Bear, Saumel Ahmadi, Stephanie Chin et al.
doi:10.1038/nbt.3294
A protocol for generating biliary epithelial cells from human pluripotent stem cells facilitates disease modeling and drug screening.

Expression of trehalose-6-phosphate phosphatase in maize ears improves yield in well-watered and drought conditions   pp862 - 869
Michael L Nuccio, Jeff Wu, Ron Mowers, Hua-Ping Zhou, Moez Meghji et al.
doi:10.1038/nbt.3277
Expression of a single trehalose transgene in maize improves yield in field trials in both well-watered and drought conditions.

See also: News and Views by Guan & Koch

Letters

Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown   pp870 - 876
Anders Wittrup, Angela Ai, Xing Liu, Peter Hamar, Radiana Trifonova et al.
doi:10.1038/nbt.3298
Live-cell imaging provides new insights in the cytosolic release mechanismsof lipid-formulated siRNAs.

High-throughput sequencing of DNA G-quadruplex structures in the human genome   pp877 - 881
Vicki S Chambers, Giovanni Marsico, Jonathan M Boutell, Marco Di Antonio, Geoffrey P Smith et al.
doi:10.1038/nbt.3295
G-quadruplex structures are detected across the human genome using a high-throughput sequencing-based approach.

Corrigenda

Corrigendum: Long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells   p882
Weida Li, Claudia Cavelti-Weder, Yinying Zhang, Kendell Clement, Scott Donovan et al.
doi:10.1038/nbt0815-882a

Corrigendum: The ethics of publishing human germline research   p882
Arun Sharma and Christopher Thomas Scott
doi:10.1038/nbt0815-882b

Corrigendum: Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun   p882
Roger G Fahmy, Alla Waldman, Guishui Zhang, Ainslie Mitchell, Nicodemus Tedla et al.
doi:10.1038/nbt0815-882c

Errata

Erratum: A mass-tolerant database search identifies a large proportion of unassigned spectra in shotgun proteomics as modified peptides   p882
Joel M Chick, Deepak Kolippakkam, David P Nusinow, Bo Zhai, Ramin Rad et al.
doi:10.1038/nbt0815-882d

Erratum: Public biotech 2013—the numbers   p882
Stacy Lawrence and Riku Lahteenmaki
doi:10.1038/nbt0815-882e

Careers and Recruitment

Top

Second-quarter biotech job picture   p883
Michael Francisco
doi:10.1038/nbt.3314

People

People   p884
doi:10.1038/nbt.3320

Advertisement
Nature Genetics in association with the Wellcome Trust present:
THE GENOMICS OF COMMON DISEASES 2015
September 2-5, 2015 | Cambridge, UK 
REGISTER NOW!
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: